Compared with patients in group 1 and group 4, patients in group 2 had a significantly higher level of hs-cTnI, a significantly higher incidence of bilateral pneumonia, and a significantly lower level of SPO2 (adjusted P < 0.05). This evidence concerns the gene TNNI3 and pneumonia.